Market Overview:
The global healthcare contract research organization (CRO) market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for CROs by pharmaceutical and biotechnology companies, rising prevalence of chronic diseases, and growing investments in life sciences research. The drug discovery segment is expected to account for the largest share of the global healthcare CRO market in 2018. This segment is projected to grow at a CAGR of 11% from 2018 to 2030. The pre-clinical segment is projected to grow at a CAGR of 10% from 2018to 2030.
Product Definition:
A healthcare contract research organization (HCRO) is a company that provides services to the pharmaceutical and biotechnology industries for the purpose of conducting clinical trials. HCROs typically provide a wide range of services, from helping companies identify potential trial sites to managing all aspects of the trial itself. The importance of HCROs lies in their ability to help drug developers bring new treatments to market more quickly and efficiently.
Drug Discovery:
The global DRUG discovery, usage and growth factor in the CRO market is expected to witness significant growth over the forecast period. Drug discovery is a process of identifying an active ingredient or drug through chemical analysis of biological samples like blood, urine, tissue or even saliva. The main objective of this procedure is to develop therapeutic drugs with lesser adverse effects and greater efficiency compared to existing drugs in the market.
Pre-Clinical:
The global pre-clinical and clinical research is carried out to support drug development for new pharmaceutical products. The healthcare contract research organization (CRO) market is expected to witness lucrative growth over the forecast period owing to increasing R&D activities, rising demand for novel drugs, and growing investments by pharmaceutical companies in CROs.
Application Insights:
The pharmaceutical industry accounted for the largest share in 2015 and is expected to continue its dominance over the forecast period. The growth of this industry can be attributed to factors such as increasing geriatric population, prevalence of chronic diseases, and growing demand for innovative drugs.
The medical device industry is anticipated to register a significant CAGR during the forecast period owing to factors such as an increase in R&D investments by companies, rise in number of clinical trials, technological advancements & new product launches. This segment also includes instrumentation that are used for diagnostic or therapeutic procedures within a hospital setting or another healthcare facility.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of CROs, increasing outsourcing activities by North American companies, and high healthcare expenditure in this region. Moreover, growing investments by governments for improving healthcare infrastructure is expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to factors such as rising medical tourism and favorable government initiatives pertaining towards quality medical services delivery system in emerging countries such as India and China. In addition, an increase in funding from public & private sectors for R&D activities will fuel growth during future years. For instance; In March 2018; The Government of Japan announced USD X billion investment plan on Improving Global Health (IHG).
Growth Factors:
- Increasing demand for contract research services from the pharmaceutical and biotechnology industries
- Rising number of clinical trials being conducted globally
- Growing focus on outsourcing of non-core activities by life sciences companies
- Proliferation of CROs with niche expertise and capabilities
- Emergence of new regions as attractive destinations for contract research
Scope Of The Report
Report Attributes
Report Details
Report Title
Healthcare Contract Research Organization Market Research Report
By Type
Drug Discovery, Pre-Clinical, Clinical
By Application
Pharmaceutical Industry, Biotechnology, Medical Device Industry
By Companies
Quintiles, ICON, LabCorp (Covance), Parexel, PPD, inVentiv Health, Charles River Laboratories, Medidata Solutions, IQVIA
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Healthcare Contract Research Organization Market Report Segments:
The global Healthcare Contract Research Organization market is segmented on the basis of:
Types
Drug Discovery, Pre-Clinical, Clinical
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical Industry, Biotechnology, Medical Device Industry
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Quintiles
- ICON
- LabCorp (Covance)
- Parexel
- PPD
- inVentiv Health
- Charles River Laboratories
- Medidata Solutions
- IQVIA
Highlights of The Healthcare Contract Research Organization Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Drug Discovery
- Pre-Clinical
- Clinical
- By Application:
- Pharmaceutical Industry
- Biotechnology
- Medical Device Industry
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Healthcare Contract Research Organization Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A healthcare contract research organization (CRO) is a company that provides contracted research services to the pharmaceutical and biotechnology industries. CROs help companies by conducting clinical trials, developing new drugs and treatments, and providing other support services related to drug development.
Some of the major companies in the healthcare contract research organization market are Quintiles, ICON, LabCorp (Covance), Parexel, PPD, inVentiv Health, Charles River Laboratories, Medidata Solutions, IQVIA.
The healthcare contract research organization market is expected to register a CAGR of 10.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Healthcare Contract Research Organization Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Healthcare Contract Research Organization Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Healthcare Contract Research Organization Market - Supply Chain
4.5. Global Healthcare Contract Research Organization Market Forecast
4.5.1. Healthcare Contract Research Organization Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Healthcare Contract Research Organization Market Size (000 Units) and Y-o-Y Growth
4.5.3. Healthcare Contract Research Organization Market Absolute $ Opportunity
5. Global Healthcare Contract Research Organization Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Healthcare Contract Research Organization Market Size and Volume Forecast by Type
5.3.1. Drug Discovery
5.3.2. Pre-Clinical
5.3.3. Clinical
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Healthcare Contract Research Organization Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Healthcare Contract Research Organization Market Size and Volume Forecast by Application
6.3.1. Pharmaceutical Industry
6.3.2. Biotechnology
6.3.3. Medical Device Industry
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Healthcare Contract Research Organization Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Healthcare Contract Research Organization Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Healthcare Contract Research Organization Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Healthcare Contract Research Organization Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Healthcare Contract Research Organization Demand Share Forecast, 2019-2026
9. North America Healthcare Contract Research Organization Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Healthcare Contract Research Organization Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Healthcare Contract Research Organization Market Size and Volume Forecast by Application
9.4.1. Pharmaceutical Industry
9.4.2. Biotechnology
9.4.3. Medical Device Industry
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Healthcare Contract Research Organization Market Size and Volume Forecast by Type
9.7.1. Drug Discovery
9.7.2. Pre-Clinical
9.7.3. Clinical
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Healthcare Contract Research Organization Demand Share Forecast, 2019-2026
10. Latin America Healthcare Contract Research Organization Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Healthcare Contract Research Organization Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Healthcare Contract Research Organization Market Size and Volume Forecast by Application
10.4.1. Pharmaceutical Industry
10.4.2. Biotechnology
10.4.3. Medical Device Industry
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Healthcare Contract Research Organization Market Size and Volume Forecast by Type
10.7.1. Drug Discovery
10.7.2. Pre-Clinical
10.7.3. Clinical
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Healthcare Contract Research Organization Demand Share Forecast, 2019-2026
11. Europe Healthcare Contract Research Organization Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Healthcare Contract Research Organization Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Healthcare Contract Research Organization Market Size and Volume Forecast by Application
11.4.1. Pharmaceutical Industry
11.4.2. Biotechnology
11.4.3. Medical Device Industry
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Healthcare Contract Research Organization Market Size and Volume Forecast by Type
11.7.1. Drug Discovery
11.7.2. Pre-Clinical
11.7.3. Clinical
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Healthcare Contract Research Organization Demand Share, 2019-2026
12. Asia Pacific Healthcare Contract Research Organization Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Healthcare Contract Research Organization Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Healthcare Contract Research Organization Market Size and Volume Forecast by Application
12.4.1. Pharmaceutical Industry
12.4.2. Biotechnology
12.4.3. Medical Device Industry
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Healthcare Contract Research Organization Market Size and Volume Forecast by Type
12.7.1. Drug Discovery
12.7.2. Pre-Clinical
12.7.3. Clinical
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Healthcare Contract Research Organization Demand Share, 2019-2026
13. Middle East & Africa Healthcare Contract Research Organization Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Healthcare Contract Research Organization Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Healthcare Contract Research Organization Market Size and Volume Forecast by Application
13.4.1. Pharmaceutical Industry
13.4.2. Biotechnology
13.4.3. Medical Device Industry
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Healthcare Contract Research Organization Market Size and Volume Forecast by Type
13.7.1. Drug Discovery
13.7.2. Pre-Clinical
13.7.3. Clinical
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Healthcare Contract Research Organization Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Healthcare Contract Research Organization Market: Market Share Analysis
14.2. Healthcare Contract Research Organization Distributors and Customers
14.3. Healthcare Contract Research Organization Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Quintiles
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. ICON
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. LabCorp (Covance)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Parexel
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. PPD
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. inVentiv Health
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Charles River Laboratories
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Medidata Solutions
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. IQVIA
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
